Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.75 GBX | -5.56% | +70.00% | -42.05% |
Apr. 02 | Europe down after Easter holiday weekend | AN |
Apr. 02 | Redx Pharma plummets on plans to delist from AIM | AN |
Sales 2024 * | 12.5M 15.54M | Sales 2025 * | - | Capitalization | 49.6M 61.68M |
---|---|---|---|---|---|
Net income 2024 * | -26M -32.33M | Net income 2025 * | -49M -60.93M | EV / Sales 2024 * | 3.58 x |
Net cash position 2024 * | 4.81M 5.98M | Net Debt 2025 * | 39.12M 48.65M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.9
x | P/E ratio 2025 * |
-1.01
x | Employees | 101 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.77% |
Latest transcript on Redx Pharma Plc
1 day | -5.56% | ||
1 week | +88.89% | ||
Current month | -31.08% | ||
1 month | -37.80% | ||
3 months | -37.80% | ||
6 months | -50.96% | ||
Current year | -42.05% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Anson
CEO | Chief Executive Officer | - | 18-05-31 |
Peter J. Collum
DFI | Director of Finance/CFO | - | 21-05-04 |
Chief Operating Officer | 46 | 18-11-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 22-01-26 |
Joseph Anderson
BRD | Director/Board Member | 65 | 23-09-05 |
Peter Presland
BRD | Director/Board Member | 75 | 17-11-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 12.75 | -5.56% | 714,827 |
24-04-17 | 13.5 | +22.73% | 1,049,536 |
24-04-16 | 11 | +22.22% | 779,645 |
24-04-15 | 9 | +9.09% | 757,519 |
24-04-12 | 8.25 | +10.00% | 2,655,479 |
Delayed Quote London S.E., April 18, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.05% | 65.38M | |
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.84% | 13.78B | |
+0.59% | 13.4B | |
+20.86% | 11.06B |
- Stock Market
- Equities
- REDX Stock